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Cell–cell adhesion is an elementary process in normal
epithelial cellular architecture. Several studies have shown
the role mediated by cadherins in this process, besides
their role in the maintenance of cell polarity, differentia-
tion and cell growth. However, during tumour progression,
these molecules are frequently altered. In breast cancer,
tumours that overexpress P-cadherin usually present a
high histological grade, show decreased cell polarity and
are associated with worse patient survival. However, little
is known about how this protein dictates the very
aggressive behaviour of these tumours. To achieve this
goal, we set up two breast cancer cell models, where
P-cadherin expression was differently modulated and
analysed in terms of cell invasion, motility and migration.
We show that P-cadherin overexpression, in breast cancer
cells with wild-type E-cadherin, promotes cell invasion,
motility and migration. Moreover, we found that the
overexpression of P-cadherin induces the secretion of
matrix metalloproteases, specifically MMP-1 and MMP-
2, which then lead to P-cadherin ectodomain cleavage.
Further, we showed that soluble P-cadherin fragment is
able to induce in vitro invasion of breast cancer cells.
Overall, our results contribute to elucidate the mechanism
underlying the invasive behaviour of P-cadherin expres-
sing breast tumours.
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Introduction
Cell migration and invasion are critical properties that
characterize malignant neoplastic cells. Recently, a
number of molecular mechanisms have been identified
in transformed cells that become migratory and invasive
during carcinogenesis. These includes alterations in
cell–cell and cell–matrix adhesion, activation of small
GTPases or modulation of receptor tyrosine kinase-
mediated signal transduction pathways (Cavallaro and
Christofori, 2004).
Cell–cell adhesion is crucial for the maintenance of
normal epithelial cellular architecture and is frequently
altered in tumour progression, inducing a multistep
process termed epithelial-to-mesenchymal transition
(EMT) (Thiery, 2002). During EMT, tumour cells
progressively downregulate their cell–cell adhesion
epithelial-specific proteins, such as E-cadherin, and
express de novo mesenchymal adhesion molecules, such
as N-cadherin. This cadherin switch leads to the
inhibition of cell–cell contacts and elicits active signals,
which support tumour cell migration, invasion and
metastatic dissemination (Frixen et al., 1991; Chen et al.,
1997). However, regardless the major progress in
understanding the in vitro molecular processes under-
lying EMT and tumour progression, a number of
questions remain unsolved. For instance, the majority
of breast cancer subtypes are diagnosed as invasive and
malignant under pathological criteria, but rarely loose
complete E-cadherin expression and infrequently gain
de novo N-cadherin expression (Sarrio et al., 2008).
Our group has been focused in studying the role
of another classical cadherin in breast cancer, namely
P-cadherin. As mentioned before, in breast cancer, many
of the highly aggressive tumours do not actually show a
cadherin switch. In contrast, these tumours overexpress
P-cadherin, maintaining the normal E-cadherin expres-
sion (Paredes et al., 2005, 2008). In clinical terms, these
P-cadherin-overexpressing tumours present high histolo-
gical grade, with decreased cell polarity, aggressive
behaviour and worse patient survival (Peralta Soler
et al., 1999; Gamallo et al., 2001; Paredes et al., 2002,
2005). On the basis of these observations, we aimed to
understand how P-cadherin, in an E-cadherin wild-type
background, could influence the behaviour of these
tumours. Thus, we have studied earlier the expression of
classical cadherins in a small collection of breast cancer
cell lines (Paredes et al., 2007), and we associated this
expression with the invasiveness potential of these cells.
Received 13 February 2009; revised 9 September 2009; accepted 16
September 2009; published online 9 November 2009
Correspondence: Dr J Paredes, IPATIMUP, Institute of Molecular
Pathology and Immunology, University of Porto, Rua Dr Roberto
Frias s/n, Porto 4200-465, Portugal.
E-mail: jparedes@ipatimup.pt
Oncogene (2010) 29, 392–402
& 2010 Macmillan Publishers Limited All rights reserved 0950-9232/10 $32.00
www.nature.com/onc
Indeed, it is possible to see that there is a significant
association between P-cadherin overexpression and the
invasion capacity of breast cancer cells that maintain the
expression of wild-type E-cadherin.
In this study, we show for the first time that
P-cadherin overexpression, in wild-type E-cadherin
breast cancer cells, is able to induce increased cell
invasion, motility and migration. Additionally, we
found that the presence of P-cadherin is able to provoke
the secretion of pro-invasive factors, such as matrix
metalloproteases (MMPs), MMP-1 and MMP-2, which
then lead to P-cadherin ectodomain cleavage. Interest-
ingly, we observed that this formed soluble P-cadherin
fragment (sP-cad) is responsible for the in vitro invasion
of wild-type E- and P-cadherin expressing cells, which
clarifies the mechanism associated to cell invasion
and may explain the poor prognosis of patients
harbouring breast tumours expressing these two mole-
cules (Paredes et al., 2008).
Results
P-cadherin overexpression in wild-type E-cadherin breast
cancer cell lines is associated with an increase in cell
invasion
In a recent study, we analysed the mRNA expression
levels of the major classical cadherins (E-, P- and N-
cadherins) among a small collection of different breast
cancer cell lines, using RT–PCR (Paredes et al., 2007).
Comparing these results with the knowledge acquired
about these cell lines in earlier publications (Figure 1a),
especially concerning their invasiveness potential, EMT
phenotype and gene expression profile (Charafe-Jauffret
et al., 2006; Lombaerts et al., 2006; Neve et al., 2006;
Blick et al., 2008), we can clearly see that E-cadherin
mRNA is only expressed by cell lines that maintain an
epithelial phenotype, whereas N-cadherin is expressed
by cells that show a mesenchymal phenotype. Besides
the phenotype, the expression of these cadherins is also
highly correlated with cell invasiveness capacity, where
E-cadherin-positive cell lines show low invasive poten-
tial, whereas N-cadherin expressing cells are widely
described as highly invasive. When breast cancer cell
lines are classified in accordance with their gene
expression profile, E-cadherin is also predominantly
expressed by both Luminal and Basal A cell lines,
whereas N-cadherin transcripts are restricted to Basal B
cell lines.
Although these associations are already well known
for E- and N-cadherin, similar findings were never
found, concerning P-cadherin expression and these cell
properties. Looking carefully to these associations
(Figure 1a), P-cadherin mRNA transcripts are predo-
minantly detected in E-cadherin-positive cells, being
mostly associated with an epithelial phenotype. Cur-
iously, this cadherin is strongly expressed by cell lines
classified as Basal A, being also associated with an
increased cell invasive capacity, compared with other
epithelial cell lines harbouring a Luminal gene expres-
sion profile. Using Matrigel invasion assay, we con-
firmed the invasion potential of two Luminal cell lines,
namely MCF-7/AZ and T47D, and two Basal A cell
lines, MDA-MB-468 and BT-20. Figure 1b shows that
cell lines with higher levels of P-cadherin expression
revealed an increased ability to invade through Matrigel.
More importantly, these results are in agreement with
what has been described in invasive primary breast
tumours, showing the clinical relevance of P-cadherin
expression in the diagnosis and prognosis of patients
with aggressive mammary carcinomas (Peralta Soler
et al., 1999; Paredes et al., 2005).
To determine whether or not P-cadherin expression is
in part responsible by the moderate/high invasive
capacity of Basal A cells lines, we set up two
E-cadherin-positive cancer cell models: (1) the stable
induction of P-cadherin overexpression in non-invasive
MCF-7/AZ cells, by retroviral infection; and (2) the
transient silencing of P-cadherin in invasive BT-20 cells,
using specific small interference RNA (siRNA). As can
be noticed in Figure 2a, these two cell models were
established and the role of P-cadherin in cell invasion
was, therefore, analysed. P-cadherin-overexpressing
MCF-7/AZ cells showed a significant increase in cell
invasion capacity, which was repressed when cells were
treated with a P-cadherin inhibitory-function antibody,
pointing to a P-cadherin-dependent cell invasion me-
chanism (Figure 2b). Identically, BT-20 invasive poten-
tial was significantly inhibited when P-cadherin was
silenced by siRNA (Figure 2c).
As a conclusion, we can state that P-cadherin-over-
expressing breast cancer cells, although maintaining its
epithelial phenotype, have selective advantage to invade
when compared with cell lines that mostly express
E-cadherin.
P-cadherin overexpression promotes cell motility
and cell migration of breast cancer cells
To further explore the function of P-cadherin in breast
cancer, its effect on cell motility and cell migration was
also tested.
We evaluated breast cancer single cell motility by
time-lapse microscopy, during 6 h of culture (see movies
in Supplementary data). Figure 3 represents snapshot
images from time-lapse movies, where differences were
seen between the motility of MCF-7/AZ.Mock and
MCF-7/AZ.Pcad cells. Figure 3 also shows the results
obtained with BT-20 cells transfected with a control
siRNA or with an siRNA that specifically abolish P-
cadherin expression. The trajectory of the cell’s nuclei
from both cell lines is showed in Figure 3a. MCF-7/
AZ.Mock cells barely showed significant movement,
whereas MCF-7/AZ.Pcad cells exhibited increased cell
motility. Besides this significant increase in the total
number of cells with motile capability, MCF-7/AZ.Pcad
cells also showed a fourfold increase in cell speed
(Figure 3b). P-cadherin silencing in BT-20 cells, turns
these cells significantly less motile, and the cell speed was
decreased for half of the one showed by BT-20 control
cells (Figures 3c and d).
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Besides analysing cell motility, we evaluated cell
migration capacity, using a wound-healing migration
assay. As observed in Figures 4a and b, P-cadherin-
positive cells migrated significantly faster into the
wound compared with control cells; importantly,
this result was not due to an increase in cell proliferation
rate of P-cadherin-overexpressing cells (Figure 4c).
To confirm that induced migration was dependent of
P-cadherin expression in these cells, the same experiment
was performed in the presence of a functionally
blocking antibody against P-cadherin activity (the
NCC-CAD-299 clone). As shown in Figure 4b,
the presence of this antibody significantly inhibited
the migration capacity of P-cadherin-overexpressing
cells into the wound area, whereas a non-specific
IgG did not. An obvious observation of P-cadherin-
induced cell migration was the evident pattern of
collective cell migration, as P-cadherin-overexpressing
cells do not lose their E-cadherin cell–cell contacts,
and cells migrate faster and cohesive. Time-lapse
microscopy movies clearly show this result (see Supple-
mentary data).
In both assays, besides the increase in cell motility and
migration, it was also possible to observe clear
differences between cell’s phenotype (see Supplementary
data), where P-cadherin-overexpressing cells presented
an increased number of membrane protrusions, struc-
tures that are usually associated to moving cells.
Figure 1 Association between P-cadherin expression and cell invasiveness in wild-type E-cadherin breast cancer cell lines. (a) Table
comparing the pattern of expression of classical cadherins (namely E-, P- and N-cadherin) in different breast cancer cell lines with their
invasiveness potential, EMT (epithelial-to-mesenchymal transition) phenotype and gene expression profile. (b) Matrigel invasion assay
was used to analyse the invasion potential of two Luminal cell lines, MCF-7/AZ and T47D and two Basal A cell lines, MDA-MB-468
and BT-20. The basal cell lines showed significant increase in cell invasion, when compared with the Luminal cell lines (*Po0.005
compared with MCF-7/AZ non-invasive cells).
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P-cadherin overexpression induces the formation of cell
membrane protrusive structures
An effective cell migration requires the integration
of localized and transient signalling events, leading
to changes in cellular architecture, namely in the
re-organization of the actin cytoskeleton. Given that
P-cadherin affects cell migration, motility and invasion,
we analysed the effect of P-cadherin overexpression on
the actin cytoskeleton organization, by F-actin fluores-
cence immunostaining. Differences between control and
MCF-7/AZ.Pcad cells were evident as P-cadherin-over-
expressing cells showed an increase in membrane
ruffling and in actin cellular extensions, as well as in
their cytoplasmic area (Figure 5). Indeed, P-cadherin-
overexpressing cells, including MCF-7/AZ.Pcad and
BT-20, show an upper cell localized nuclei and appear
as rounded and flat cells with actin-rich sheet-like
membrane protrusive structures that, according with
the literature, are essentially observed during crawling
cell motility and spreading (Yamazaki et al., 2005;
Chhabra and Higgs, 2007).
Using double F-actin and p120ctn staining,
MCF-7/AZ.Mock versus MCF-7/AZ.Pcad cells showed
distinct aggregation ability, where MCF-7/AZ.Mock
cells, in contrast to P-cadherin-overexpressing cells,
showed well-formed and tight aggregates (Figure 5).
Indeed, microscopic fluorescence imaging of P-cadherin
expressing cells showed that P-cadherin destabilizes
cell–cell adhesion, promoting cytoskeleton changes,
leading to a different cell phenotype. The cells resemble
the aggressive morphology observed in primary basal-
like P-cadherin-positive breast carcinomas, as these cells
normally acquire a large cytoplasm and several mem-
brane protrusions, and cell–cell adhesion is not usually
mediated by a compact zipper-like structure (Yamazaki
et al., 2005; Chhabra and Higgs, 2007).
These results clearly show an association between
P-cadherin expression and actin cytoskeleton reorgani-
zation, suggesting that P-cadherin has a role in the
mechanism that regulates the cellular architecture
changes that are needed to promote cell migration and
invasion.
P-cadherin overexpression induces active MMPs that are
responsible for its extracellular cleavage and shedding
One of the families of proteases, which are well known
to be involved in cell invasion induction, namely in the
extracellular matrix (ECM) degradation process, is the
family of MMPs. On the basis of this, MMP activity
levels were assessed in the conditioned medium from
P-cadherin-overexpressing breast cancer cells, using
b-casein and gelatin zymography. The results obtained
showed that P-cadherin expression induces significantly
the levels of active MMP-1 (42 kDa) and active MMP-2
(66 kDa) in the conditioned medium compared with
control cells (Figure 6a). These observations were
further confirmed by western blot, using antibodies
specifically to analyse the expression of inactive and
active forms of MMP2 and MMP1 (Figure 6b).
Accordingly, also high levels of active MMP-1 and
MMP-2 were found in the conditioned medium from
BT-20 cells, although transient P-cadherin silencing was
not enough to abrogate the expression levels of these
active MMP forms (data not shown).
Given that MMPs were already described to shed the
extracellular domains of membrane glycoproteins,
including E-cadherin, giving rise to a soluble fragment
with pro-invasive activity (Lochter et al., 1997;
Herren et al., 1998; Noe et al., 2001), we looked forward
for the presence of soluble fragments of cadherins in
the conditioned medium from the studied cell lines.
Surprisingly, no significant differences were observed
Figure 2 P-cadherin is involved in breast cancer cell invasion.
(a) P-cadherin and a-tubulin protein expression in two different
breast cancer cell models: induction of P-cadherin overexpression
in MCF-7/AZ cells, by retroviral infection, and silencing of
P-cadherin overexpression in BT-20 cells, using specific small
interference RNA (siRNA). (b) Matrigel invasion assay of control
MCF-7/AZ.Mock cells, and MCF-7/AZ.Pcad cells in the absence
or presence of a function-blocking anti-P-cadherin antibody (NCC-
CAD-299, P¼ 0.0029 and 0.0022, respectively). (c) Matrigel
invasion assay of BT-20 siRNA control cells compared with
BT-20 with P-cadherin knockdown expression (P¼ 0.0019).
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concerning the presence of soluble E-cadherin (sE-cad);
however, sP-cad was increased 8.7-fold in the condi-
tioned medium from MCF-7/AZ.Pcad cells (Figure 6c).
BT-20 cells also showed high levels of sP-cad, which
were significantly decreased when these cells were
transfected with P-cadherin siRNA (Figure 7a). These
results showed, as expected, a direct association between
full-length P-cadherin overexpression at the cell mem-
brane and the presence of sP-cad in the conditioned
media.
Finally, our goal was to assess if MMPs might have a
role in P-cadherin shedding, as was described earlier for
Figure 3 Promotion of cell motility by P-cadherin overexpression in breast cancer cells. Snapshot images from time-lapse movies of
MCF-7/AZ.Mock and MCF-7/AZ.Pcad cells (a) and BT-20 siRNActr and BT-20 siRNAPcad (c). Cells were monitored during 6 h,
and trajectories for each cell were determined manually based on the centre of the nuclei along time. Black lines represent the
trajectories performed by cells. Cell speed, considering the ratio from the distance made by cells versus the time of movement, was
quantified for MCF-7/AZ.Mock and MCF-7/AZ.Pcad cells (b) and for BT-20 siRNActr and BT-20 siRNAPcad (d), where 300 cells
were analysed per cell line (Po0.001). In both cell models, is possible to conclude that P-cadherin expression promotes an increase in
cell motility and cell speed.
Figure 4 Induction of cell migration by P-cadherin overexpression in breast cancer cells. (a) Cell migration was estimated by means of
wound-healing migration assay, and monitored by time-lapse microscopy. The distances migrated by breast cancer cells were measured
at several time points: 0, 1, 2, 3, 4, 5 and 6 h. The experiment shown is relative to a representative experiment that was repeated three
times. (b) Migration of MCF-7/AZ.Mock and MCF-7/AZ.Pcad cell lines, in the presence or absence of a function-blocking
anti-P-cadherin antibody (NCC-CAD-299) was evaluated by wound-healing migration assay (*Po0.05, corresponding to P-values
from MCF-7/AZ.Pcadþ IgG compared with MCF-7/AZ.Mockþ IgG cells; **Po0.05, ***Po0.01, corresponding to P-values from
MCF-7/AZ.Pcadþ IgG compared with MCF-7/AZ.PcadþNCC-CAD-299 antibody treatment). P-cadherin expression is directly
implicated in the migratory capabilities of this cell line. (c) BrdU proliferation assay was performed in MCF-7/AZ.Mock and MCF-7/
AZ.Pcad cells, to exclude that differences observed in cell migration were due to altered cell proliferation. No differences were observed
in the percentage of cell proliferation in both cell lines.
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E-cadherin. Thus, MCF-7/AZ.Pcad cells were treated
with a MMP inhibitor (with higher affinity to inhibit
MMP-1 and MMP-2), the conditioned medium was
recovered and the presence of sP-cad was evaluated by
western blot. Remarkably, the treatment with the MMP
inhibitor reduced the levels of sP-cad, showing that
MMPs have an important role in P-cadherin cleavage
and shedding (Figure 6d). To understand if P-cadherin
shedding had also a role in the production of MMPs,
inducing a mechanism of positive feedback, the parental
cell line MCF-7/AZ was treated with human recombi-
nant P-cadherin (hrP-cad). This peptide should mimic
the effect of sP-cad, as it only harbours the extracellular
part of this complete adhesion molecule. Interestingly,
we found that hrP-cad induced the secretion of active
MMP-1 and MMP-2, as happens in MCF-7/AZ.Pcad
cells (Figure 6e). We also showed that hrP-cad is also
cleaved by MMPs, originating an 80 kDa fragment,
identical to sP-cad; the levels of this fragment were
decreased when cells were treated with hrP-cad in
combination with MMP inhibitor, confirming the
importance of these MMPs to full-length P-cadherin
cleavage (Figure 6f).
These results show that P-cadherin overexpression,
sP-cad cleavage, as well as active MMPs secretion, are
highly correlated. Briefly, P-cadherin expression leads to
the secretion of active MMPs, enzymes that then cleave
the extracellular domain of P-cadherin, giving rise to
sP-cad. This soluble fragment is able to induce and
maintain the secretion of active MMPs.
sP-cad has pro-invasive activity in breast cancer cells
As a crucial step for invasion and metastasis is the
destruction of biological barriers (basement membrane
and ECM) by activated proteolytic enzymes, we aimed
to assess whether the medium from P-cadherin-over-
expressing breast cancer cells, rich in MMPs and sP-cad,
was enough to facilitate cell invasion of non-invasive
cells. Thus, we performed the same invasion assay using
the parental MCF-7/AZ cell line, treated with the
conditioned medium obtained from MCF-7/AZ.Mock
and MCF-7/AZ.Pcad cells (Figures 7a and b). Interest-
ingly, only the conditioned medium from P-cadherin-
overexpressing cells itself was able to significantly induce
invasion. This effect was not observed in the presence of
the conditioned medium secreted by cells without
P-cadherin overexpression (MCF-7/AZ.Mock). To con-
firm these results, these same cells were treated with the
conditioned medium from BT-20 cells, which also
contain high levels of sP-cad and MMPs, and ‘de novo’
invasive cell behaviour was observed. These results show
that P-cadherin-overexpressing cells secrete factors to
the medium that are crucial for cell invasion induction
(Figures 7a and b).
In the past, in vitro studies showed that sE-cad has a
pro-invasive role in tumour cell lines, although its
mechanism of action is still not well understood (Noe
et al., 2001). However, the potential activity of sP-cad in
cell invasion induction has never been described in
in vitro studies. To understand whether sP-cad would
have a role in breast cancer cell invasion, we depleted the
Figure 5 P-cadherin overexpression induces the formation of cell membrane protrusions and large cytoplasm. Breast cancer cells were
seeded on a glass surface, fixed and stained for P-cadherin (I, IV, VII). FITC-phalloidin staining was also performed (II, V, VII), to
visualize actin filaments (1000 amplification), where it was possible to confirm alterations in the actin cytoskeleton re-organization in
P-cadherin-overexpressing cells. Confocal microscopy imaging of aggregates from MCF-7/AZ.Mock (III), MCF-7/AZ.Pcad (VI) and
BT-20 cells (IX), stained for F-actin (green) and p120ctn (red) (400 amplification) was performed. Cell phenotype and structure of
cell clusters were different, attributing a role for P-cadherin in the induction of loose aggregates. The white line in each picture
represents 20 mm scale.
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sP-cad fragment from the conditioned medium of MCF-7/
AZ.Pcad cells by repeated immunoprecipitations,
using a specific P-cadherin antibody (Figures 7a and b).
Moreover, we treated the cells with hrP-cad, which was
added to the conditioned medium collected from
MCF-7/AZ.Mock cells. Afterwards, we performed
Matrigel invasion assay using the parental non-invasive
MCF-7/AZ cells, treated with these mediums: or with
the hrP-cad-rich medium or with the depleted (without
sP-cad) conditioned medium of P-cadherin-overexpres-
sing cells. Although hrP-cad-rich medium promoted cell
invasion capacity to a non-invasive cell line, this effect
was completely abolished when sP-cad was depleted
from the medium (Figures 7a and b). Moreover, when
MCF-7/AZ cells were treated with the conditioned
medium from BT-20 cells, where P-cadherin was
silenced by siRNA, its invasion was significantly
reduced comparing with BT-20 control cells. Together,
these results clearly show a critical role for sP-cad in
breast cancer cell invasion.
Finally, to understand whether the invasion effect
induced by sP-cad was due to homotypic interactions
with endogenous P-cadherin on the surface of the cells,
we decided to measure the invasion rates of BT-20 target
cells, with P-cadherin siRNA knockdown, exposed to
conditioned medium rich in sP-cad or rich in hrP-cad
(Figure 7c). Interestingly, we found that in both
situations, it is possible to restore the invasion capacity
of these cells. These results show that the invasive effect
mediated by sP-cad is not due to a homotypic
interaction with endogenous P-cadherin at the cell
membrane.
Discussion
Previous studies have shown that P-cadherin expression
in breast carcinomas is able to identify a subgroup of
lesions with a more aggressive behaviour and poor
Figure 6 P-cadherin overexpression induces increased levels of MMP-1 and MMP-2 activity, which have a role in P-cadherin
shedding. (a) b-casein zymography, which allows identification of activity of MMP-1 and MMP-2, was performed using the
conditioned medium from mock and MCF-7/AZ.Pcad cells, cultured in collagen type-I. (b) Western blot to detect the secretion of
active-MMP-1 and active-MMP-2 into the conditioned medium was evaluated and compared between mock and P-cadherin-
overexpressing cells. (c) Detection for the presence of sE-cadherin and sP-cadherin fragments in the medium was achieved by
performing western Blot for these proteins, using the conditioned medium obtained from each cell line. (d) Effect of MMPs in
the shedding of P-cadherin was evaluated by analysing the presence of the sP-cad fragment in the conditioned medium from
MCF-7/AZ.Pcad cells treated with different concentrations of the MMP inhibitor III. (e) Zymography detecting increased MMP-2
activity levels in parental MCF-7/AZ cells treated with a human recombinant fragment of P-cadherin (hrP-cad). Western blot for
active-MMP-1 and active-MMP-2 present in the conditioned medium from control cells treated with hrP-cad. (f) Protein expression
analysis for the conditioned medium from control cells treated with hrP-cad and MMPi, to confirm that hrP-cad can be shed to an
80 kDa form and that this process is MMP dependent.
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patient survival (Peralta Soler et al., 1999; Gamallo
et al., 2001; Paredes et al., 2002, 2004, 2005, 2007, 2008).
Similar associations between P-cadherin expression and
poor prognosis are described in other cancer models,
namely endometrial, cervical, gastric and pancreatic
carcinomas (Stefansson et al., 2004; Longatto Filho
et al., 2005; Taniuchi et al., 2005).
Our group has previously shown in vitro that, using
HEK 293 T cells as a model system, P-cadherin has a
pro-invasive activity, through its juxtamembrane do-
main (Paredes et al., 2004). In contrast, in highly
invasive melanoma cell lines, P-cadherin overexpression
is able to promote the formation of cell–cell contacts
and counteract invasion (Van Marck et al., 2005),
showing that it may function either as an invasion
promoter or as an invasion suppressor depending on
tissue specificity. On the basis of clinical evidences and
on its contradictory biological role in distinct tumour
tissues, we aimed at understanding how P-cadherin
influences tumour aggressiveness. Furthermore, we
aimed to clarify, besides cell invasion, its role in
migration, motility and activation of MMPs, using
breast cancer-derived cell lines.
Using in vitro cell models, we found for the first time
that overexpression of exogenous P-cadherin is able to
promote single cell motility, inducing an increase in the
number of moving cells and speed when compared with
cells with low levels of this protein. Furthermore,
P-cadherin-overexpressing cells not only showed in-
creased single cell motility, but also increased directional
cell migration, as well as, invasion capacity through the
Matrigel. This behaviour was shown to be directly
dependent on P-cadherin, as when overexpressing cells
were treated with a P-cadherin blocking antibody or
transfected with a siRNA to inhibit P-cadherin tran-
scripts, there was an inhibition of both effects (migra-
tion and invasion). Interestingly, Simpson et al. (2008)
also identified CDH3 (the P-cadherin codifying gene) as
one of the genes involved in the regulation of breast cell
migration using an siRNA approach. Further, in other
studies, using different cancer cell models, P-cadherin
was shown to have a role in promoting cell migration.
Namely, Taniuchi et al. (2005) showed that a pancreatic
cancer cell line, transfected with wild-type P-cadherin,
migrated faster than the cells without this molecule.
Epithelial cell migration requires the coordination of
three basic cellular processes: actin cytoskeleton reorga-
nization, matrix adhesion and matrix re-modelling
(Lauffenburger and Horwitz, 1996; Fenteany et al.,
2000). In this present study, we also show, by time-lapse
microscopy and actin phalloidin staining, that P-cadherin
is able to induce phenotypic changes involving alterations
in cell polarity and leading edge morphology, formation
of membrane protrusions, as well as, increase of their
cytoplasmic area, which usually is characteristic from
cells with a motile behaviour.
Further, we aimed to determine the molecular
mechanisms underlying P-cadherin overexpression and
its cellular-associated effects in breast cancer cells. It has
been described that the degradation of the ECM, with
recruitment of proteolytic enzymes, occurs in a variety
of cellular events requiring tissue reorganization, such as
embryonic development, wound healing and cancer
progression (Vu and Werb, 2000). Among these
enzymes, MMPs are able to degrade almost all the
ECM components, and have largely been involved in
both tumour invasion in vitro and in early and late
stages of tumour progression in vivo. When we evaluated
the cell invasion capacity of non-invasive parental cells
exposed to conditioned media from P-cadherin-over-
Figure 7 sP-cad has pro-invasive activity. (a) Western blot for
several conditioned medium, showing different levels of sP-cad.
Conditioned medium from MCF-7/AZ.Pcad cells (with sP-cad)
was subjected to serial immunoprecipitations for the sP-cad
fragment, using a specific monoclonal P-cadherin antibody,
originating the conditioned medium with sP-cad depletion. (b) To
clarify the specific role of s-Pcad in breast cancer cell invasion,
matrigel invasion assay was performed in non-invasive parental
MCF-7/AZ cells incubated with the conditioned medium from
the different cell lines that present different levels of sP-cad
(shown in a). Control cells were treated conditioned medium from
MCF-7/AZ.Mock cells (with and without hrP-cad), conditioned
medium from MCF-7/AZ.Pcad cells (with and without sP-cad
depletion) and with conditioned medium from BT-20 cells (with
and without P-cadherin knockdown). Student’s t-test was per-
formed and the statistically different values are indicated (*Po0.05
and **Po0.01 compared to control conditioned medium). (c) To
understand whether the invasion effect induced by sP-cad was due
to homotypic interactions with endogenous P-cadherin on the
surface of the cells, we calculated the invasion rates of BT-20 with
P-cadherin knockdown, exposed to conditioned medium from BT-
20 control cells (rich in sP-cad) or rich in hrP-cad. We observed a
rescue in the invasion capacity of these cells.
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expressing cells, we conclude that indeed P-cadherin
induces the secretion of factors that facilitate cell
invasion of non-invasive MCF-7/AZ cells that we
identified as being active forms of MMP-1 and
MMP-2. More importantly, we showed that these enzymes
are responsible by the shedding of a soluble extracellular
fragment of P-cadherin harbouring pro-invasive activ-
ity, as its depletion from the conditioned medium of
P-cadherin-overexpressing cells re-establish the non-
invasive phenotype of E-cadherin breast cancer cells.
Our results are in accordance with several recent
studies, concerning the role of MMP-2, MMP-1 and
sP-cad in breast cancer. In vivo, MMP-2 is described as a
key enzyme for the degradation of the ECM and
facilitating tumour invasion and metastasis, being its
active form present in half of all human breast
carcinomas (Stetler-Stevenson et al., 1993; Remacle
et al., 1998). Not only MMP-2 has pro-invasive
activities, but also MMP-1 overexpression has been
shown in a variety of advanced carcinomas, being
associated with poor prognosis (Murray et al., 1998a, b;
Ito et al., 1999; Fujimoto et al., 2008; Okuyama et al.,
2008). High levels of MMP-1 expression have been
detected in human breast cancer cells with elevated
metastatic capacity towards the bone, providing evi-
dence for its role in cancer cell invasion and metastasis
(Kang et al., 2003; Okuyama et al., 2008). However, the
molecular mechanism by which P-cadherin expression
induces the secretion of these both enzymes to the
medium remains unsolved.
The mechanism of ectodomain cleavage of adhesion
proteins, mediated by MMPs, has been already well
described (Lochter et al., 1997; Herren et al., 1998; Noe
et al., 2001). MMP-3 and MMP-7 have a role in the
shedding of the extracellular domain of E-cadherin,
generating a soluble 80 kDa fragment (Noe et al., 2001).
Interestingly, the sE-cad fragment, when released,
inhibits E-cadherin functions in a paracrine way,
inducing cell invasion into collagen type I and inhibiting
E-cadherin-dependent cell–cell aggregation (Noe et al.,
2001). Very recently, Mannello et al. (2008) showed a
significant increased shedding of soluble fragments of P-
cadherin in nipple aspirate fluids from women with
breast cancer, when compared with healthy subjects or
with women with pre-cancer conditions. This suggests
its possible release through proteolytic processing in
cancer cells. Until nowadays, there are only few studies
showing the presence of sP-cad in biological human
fluids (such as milk (Soler et al., 2002) and sperm (De
Paul et al., 2005)), but no specific cellular effect has been
attributed to this fragment. Our results show, for the
first time, that sP-cad is produced by proteolytic
enzymes (MMP-1 and MMP-2) and is responsible for
the invasive capacity of breast cancer cells. Moreover,
this invasive effect induced by sP-cad is independent
from the endogenous expression of P-cadherin at the cell
membrane. Further research is needed to elucidate
which signalling pathways are activated by this pro-
invasive factor.
In conclusion, the results herein described contribute
to clarify the role of P-cadherin expression in breast
cancer, as they unravel the molecular mechanism and
the associated cellular effects mediated by this protein.
In breast cancer cells, P-cadherin expression gives an
advantage to cells to migrate and move, as well as the
possibility to secrete pro-invasive factors, such as MMPs
and sP-cad.
Materials and methods
Cell culture and transfection
Human cancer cell lines were obtained as described: MCF-7/
AZ (kindly given by Prof. Marc Mareel, Ghent University,
Belgium), T47D, MDA-MB-468 and BT-20 from American
Type Culture Collection (Manassas, VA, USA). Cell lines were
routinely maintained at 37 1C, 5% CO2, in the following media
(Invitrogen Ltd, Paisley, UK): 50% DMEM/50% HamF12
(MCF-7/AZ), DMEM (BT-20, T47D, MDA-MB-468). All the
media contained 10% heat-inactivated fetal bovine serum
(Greiner bio-one, Wemmel, Belgium), 100 IU/ml penicillin and
100 mg/ml streptomycin. MCF-7/AZ cell line was retrovirally
stable transduced to encode P-cadherin (MCF-7/AZ.Pcad cell
line), as described earlier (Paredes et al., 2004). MCF-7/
AZ.Mock cell line, encoding only EGFP, was used as a
control. BT-20 transient transfection with siRNA specific for
P-cadherin (50 nM, Hs_CDH3_6, GW Validated siRNA,
Qiagen, Cambridge, MA, USA) was carried out using
Lipofectamine 2000 (Invitrogen), according to the manufac-
turer’s procedures. A negative control, with no homology to
any gene, was also used (Qiagen).
For the conditioned medium assays, cells were grown until
confluence in collagen-type I-coated flasks (0.2mg/ml—Sigma,
Steinheim, Germany) and incubated in serum-free medium for
48 h. The conditioned medium was filtered and the proteins
secreted were quantified in the recovered supernatant.
Antibodies and chemicals
Primary antibodies. P-cadherin (Western blot: clone 56, BD
Biosciences, Lexington, KY, USA; immunofluorescence: Cell
Signalling tecnhology, Boston, MA, USA; P-Cadherin-block-
ing-function antibody: clone NCC-CAD-299, Zymed Labora-
tories, San Francisco, CA, USA), E-cadherin (clone HECD-1,
Takara Bio Inc., Shiga, Japan), p120ctn (clone 98, BD
Biosciences), b-actin (I-19, Santa Cruz Biotechnologies, CA,
USA), MMP-1 and MMP-2 (Ab-6 and Ab-7 respectively,
Neomarkers, Fremont, CA, USA).
Chemicals. MMP inhibitor III (treatement with 10 nM or
100 nM, for 48 h, Calbiochem, EMD Chemicals, Darmstadt,
Germany); Recombinant human P-cadherin/Fc chimaera
(20mg/ml; hrPcad, R&D Systems, Inc., Minneapolis, MN,
USA). For detailed description see Supplementary data.
Cancer cell motility and wound-healing assay
For the motility assay, cells were monitored with an inverted
time-lapse controller (Leica FW 4000, DMIRE 2, Pecon,
Leica, Bensheim, Germany) and distance moved by the cells
was determined, as well as cell speed (mm/h).
For the wound-healing migration assay, wounds were made
across the cell monolayer and distances between the wound
edges were determined. Cells were also treated with NCC-
CAD-299 (100 mg/ml) or control mouse immunoglobulin G
(IgG; 100 mg/ml, Upstate, Millipore, Billerica, MA, USA).
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BrdU proliferation assay was performed to exclude that
difference in cell migration was due to cell proliferation. For
detailed description see Supplementary data.
Immunofluorescence and confocal microscopic analysis
Cells were plated on glass coverslips (Becton Dickinson
Labware, Franklin Lakes, NJ, USA), fixed with 4% for-
maldehyde. For protocol details see Supplementary data.
Gelatin and b-casein zymography
The conditioned medium was analysed for proteinases activity
using gelatin and b-casein zymography (gels loaded with 12
and 100mg of protein, respectively) as described earlier
(Oliveira et al., 2003). Quantification of band density was
done using the Quantity One software (version 4.0, Bio-Rad,
Hercules, CA, USA), unless specified.
Immunodepletion and western blot
For sP-cad immunodepletion, 300ml of conditioned medium
collected from MCF-7/AZ.Pcad cells was incubated with
NCC-CAD-299 and immunoprecipitated twice. Western Blot
was performed as described earlier (Paredes et al., 2007).
The experiments selected to show are representative ones. For
more detailed description on immunoprecipitation and western
Blot see Supplementary data.
Matrigel invasion assay
Matrigel invasion assay was performed according to manu-
facter’s instrutions (BD Biosciences). For more detailed
description see Supplementary data.
Statistical analysis
Data are expressed as mean values of at least three
independent experiments±s.d. Student’s t-tests were used to
determine statistically significant differences (Po0.05).
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